Monitoring Sanofi (SNY) after recent insider movements

0
24

Taking this into account, A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who increased its forecast for the stock in mid August from “a Sell” to “a Hold”. UBS also remained covering SNY and has decreased its forecast on August 09, 2022 with a “Neutral” recommendation from previously “Buy” rating. SVB Leerink started covering the stock on May 23, 2022. It rated SNY as “an Outperform”.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Price Performance Review of SNY

On Tuesday, Sanofi [NASDAQ:SNY] saw its stock fall -0.21% to $48.53. On the same session, the stock had its day’s lowest price of $48.24, but rose to a high of $48.60. Over the last five days, the stock has lost -2.61%. Sanofi shares have risen nearly 0.21% since the year began. Nevertheless, the stocks have fallen -4.78% over the past one year. While a 52-week high of $57.79 was reached on 01/17/23, a 52-week low of $36.91 was recorded on 01/05/23. SMA at 50 days reached $46.98, while 200 days put it at $47.15. A total of 3.65 million shares were traded, compared to the trading of 1.54 million shares in the previous session.

Levels Of Support And Resistance For SNY Stock

The 24-hour chart illustrates a support level at 48.31, which if violated will result in even more drops to 48.10. On the upside, there is a resistance level at 48.67. A further resistance level may holdings at 48.82. The Relative Strength Index (RSI) on the 14-day chart is 52.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 54.90%. Stochastics %K at 53.59% indicates the stock is a holding.

How much short interest is there in Sanofi?

A steep rise in short interest was recorded in Sanofi stocks on Oct 13, 2022, growing by 1.04 million shares to a total of 4.95 million shares. Yahoo Finance data shows the prior-month short interest on Sep 14, 2022 was 3.91 million shares. There was a rise of 21.01%, which implies that there is a positive sentiment for the stock.

Sanofi [SNY] – Who Are The Largest Shareholders?

In filings from Dodge & Cox, it is revealed that the company now owns 75,650,666 shares, or roughly 2.98% of the outstanding SNY shares. In other words, the investor’s shares have fallen by -1,346,616 from its previous 13-F filing of 76997282.0. Additionally, Boston Partners Global Investors, increased 48.93% of its stake after which the total value it holdings stand at $858,334,528, while Fisher Asset Management LLC reduced -20.59% of its stake to hold $677.32 million in the firm. Over the last quarter, T. Rowe Price Associates, Inc. sold -4,947,478 shares of Sanofi, while Fidelity Management & Research Co sold 356,509 shares. At present, Managed Account Advisors LLC is holding 7,605,098 shares valued at $368.31 million. Camber Capital Management LP owned 7,500,000 shares of the company at the time of its most recent 13F filing, worth $363.23 million.

According to FactSet, Sanofi’s share price will average $56.70 in the next year, based on opinions of analysts polled by the firm. This is up nearly 16.82 percent from its previous closing price of $48.63. Analysts expect Sanofi stock to reach the higher price of $69.54, while the lowest price estimate is $44.71. However, 23 analysts have rated SNY stock as an Overweight in their predictions for 2023.

LEAVE A REPLY

Please enter your comment!
Please enter your name here